首页> 外文期刊>Modern Pathology >Distinct spatial expression patterns of AP-2alpha and AP-2gamma in non-neoplastic human breast and breast cancer
【24h】

Distinct spatial expression patterns of AP-2alpha and AP-2gamma in non-neoplastic human breast and breast cancer

机译:AP-2alpha和AP-2gamma在非肿瘤性人类乳腺癌和乳腺癌中的独特空间表达模式

获取原文
           

摘要

Although transcription factors AP-2alpha and AP-2gamma have been implicated in the control of estrogen receptor (ER) and ErbB-2, their impact for breast cancer is still controversial. To better understand the role of AP-2 proteins in mammary neoplasia, the analysis of their spatial expression pattern in normal breast and breast cancer is required. A total of 51 specimens of female breast cancer patients and a tissue microarray containing 93 additional female breast cancer cases were immunohistochemically stained for AP-2alpha, AP-2gamma, ER and ErbB-2. In 70 cases of the tissue microarray, survival data comprising a period of up to 30 years were present. In non-neoplastic breast tissue, AP-2alpha was expressed in the inner glandular cell layer while AP-2gamma was expressed in the outer myoepithelial cell layer. Ductal carcinoma in situ revealed strongly AP-2alpha-positive tumor cells surrounded by a layer of AP-2gamma-positive myoepithelial cells. In invasive carcinoma, expression of AP-2alpha and AP-2gamma was variable. High expression of ER and AP-2alpha showed better survival rates than low expression of these markers. AP-2gamma expression had no effect on survival. These results for the first time reveal a distinct spatial expression pattern of AP-2alpha and AP-2gamma in normal breast and in ductal carcinoma in situ with specific AP-2gamma expression in myoepithelium. High ER and AP-2alpha expression in invasive breast cancer showed favorable survival rates. Therefore, AP-2alpha expression seems to be associated with better prognosis of breast cancer. AP-2gamma expression has no influence on survival reflecting that myoepithelial cells are not involved in the neoplastic process.
机译:尽管转录因子AP-2alpha和AP-2gamma参与了雌激素受体(ER)和ErbB-2的控制,但它们对乳腺癌的影响仍存在争议。为了更好地了解AP-2蛋白在乳腺肿瘤中的作用,需要分析其在正常乳腺癌和乳腺癌中的空间表达模式。总共对女性乳腺癌患者的51个标本和包含93个女性乳腺癌患者的组织芯片进行了组织化学染色,以进行AP-2alpha,AP-2gamma,ER和ErbB-2的染色。在70例组织微阵列中,存在的生存数据长达30年。在非肿瘤性乳腺组织中,AP-2alpha在腺内细胞层中表达,而AP-2γ在肌上皮细胞外层中表达。导管原位癌显示强烈的AP-2alpha阳性肿瘤细胞被一层AP-2γ阳性肌上皮细胞包围。在浸润性癌中,AP-2alpha和AP-2gamma的表达是可变的。 ER和AP-2alpha的高表达显示出比这些标志物的低表达更好的存活率。 AP-2γ表达对生存没有影响。这些结果首次揭示了正常乳腺和原位导管癌中AP-2alpha和AP-2gamma的独特空间表达模式,并且在肌上皮中有特定的AP-2gamma表达。浸润性乳腺癌中较高的ER和AP-2alpha表达显示出良好的生存率。因此,AP-2alpha表达似乎与乳腺癌的更好预后相关。 AP-2γ的表达对存活没有影响,反映肌上皮细胞不参与赘生物的形成过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号